Precision Therapeutics (Pittsburgh, PA) developer of diagnostics to determine likely response to a various cancer drugs or combinations, closed a $43M Series F financing. Participants include Longitude Venture, Adams Capital Management, Quaker BioVentures, Birchmere Ventures, Techno Venture Management and Draper Triangle Ventures.